OM1 Real-World Analytics

Request a meeting
A complimentary suite of analytic reports that allow you to understand your market with deep, precision insights on your brand’s performance, outside of fill rate indicators.
Discover why patients choose to discontinue a medication, correlate discontinuation with patient outcomes and provider prescribing behaviors, and start integrating into your brand strategy today!
Compare Meds
Reason for Discontinuation Report
Level Up Brand strategy

Derived from Real-World-Data and deep clinical notes to view the experiences and patterns driving patient and provider decisions:

RfD

Reason for Discontinuation

Comprehensive insights into why a patient discontinued a medication:

  • Comparator analysis
  • Patient demographics
  • Extracted from clinical notes

Comparative Outcomes

Comparative Outcomes

Demonstrate value and effectiveness of your medication with:

  • Patient reported & other outcomes
  • Comparative effectiveness
  • Patient demographics

Prescriber Trends

Prescriber Trends

Understand complexities of prescribing patterns by:

  • Disease severity
  • Patient demographics
  • Provider characteristics

Reason for Discontinuation

Employs AI-processed, verbatim provider descriptions for reasons for discontinuation and large data on prescriptions, switches, and discontinuations to provide a comprehensive view of why certain drugs are discontinued for specific types of patients.

RA  |  PsA  |  AS  |  PsO  |  AD  |  MDD  |  BP1  |  SCZ

Comparative Outcomes

Leverages extensive patient outcomes data extracted from unstructured clinical notes to provide information on the effectiveness and comparative effectiveness of medications across various outcomes, and over time. The reports combine disease outcome metrics with patient demographics and geography to give a comprehensive view of patient disease activity and response to treatment over time across different patient characteristics.

RA  |  PsA  |  AS  |  PsO  |  AD  |  MDD  |  BP1  |  SCZ

Prescriber Trends

Delivers insights on trends in provider prescribing behaviors by comparing the relative share of prescriptions in the market over time, and across several provider and patient factors. The report pairs patient demographics and clinically deep disease characteristics as provider characteristics with longitudinal prescribing data to help customers understand the complexities of prescribing patterns

RA  |  PsA  |  AS  |  PsO  |  AD  |  MDD  |  BP1  |  SCZ

 

Request a Meeting

Real-World Analytics